Bristol Myers Squibb agreed to buy schizophrenia drug maker Karuna Therapeutics in a $14 billion deal.

Share:
More In Business
Will We See A Recession In 2025?
Managing Principal and CEO of Peachtree Group, Greg Friedman, joins Cheddar's Dave Briggs to discuss the possibility of a recession in 2025. Watch!
Load More